BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3962178)

  • 21. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.
    Martins C; Bale C; Garly ML; Rodrigues A; Lisse IM; Andersen A; Eriksson M; Benn CS; Whittle H; Aaby P
    Vaccine; 2009 Aug; 27(38):5220-5. PubMed ID: 19596409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles immunity in the first year after birth and the optimum age for vaccination in Kenyan children. Collaborative study by the Ministry of Health of Kenya and the World Health Organization.
    Bull World Health Organ; 1977; 55(1):21-31. PubMed ID: 302153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?).
    Kanra G; Ceyhan M
    Turk J Pediatr; 1991; 33(4):217-20. PubMed ID: 1814038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of placentally transmitted antibodies for measles in infants 3 to 11 months old in an urban slum community.
    Deivanayagam N; Vasudevan S; Krishnamurthy PV; Shankar VJ; Ashok TP; Nedunchelian K; Mala N; Ahmed SS
    Indian Pediatr; 1990 Sep; 27(9):919-23. PubMed ID: 2286435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age of measles immunization in tropics.
    Mirchamsy H; Shafyi A; Mahinpour M; Nazari P
    Dev Biol Stand; 1978; 41():191-4. PubMed ID: 572788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
    Liu BY; Feng ZX; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protecting infants against measles in England and Wales: a review.
    Manikkavasagan G; Ramsay M
    Arch Dis Child; 2009 Sep; 94(9):681-5. PubMed ID: 19457878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children.
    Arpadi SM; Markowitz LE; Baughman AL; Shah K; Adam H; Wiznia A; Lambert G; Dobroszycki J; Heath JL; Bellini WJ
    Pediatrics; 1996 May; 97(5):653-7. PubMed ID: 8628602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serological evaluation of immunization against measles with 2 doses administered at 6 and 11 months of age: a prospective study].
    Pannuti CS; de Souza VA; Sato HK; Fink MC; Ribeiro MI; Hisi SK; Castelo A; de Mendonça JS
    Rev Inst Med Trop Sao Paulo; 1990; 32(6):450-5. PubMed ID: 2135492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disappearance of measles antibody in Thai infants after birth.
    Vanprapar N; Chavalittamrong B; Chearskul S; Pimolpan V
    Southeast Asian J Trop Med Public Health; 1983 Dec; 14(4):488-90. PubMed ID: 6673124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Appropriate age for measles vaccination in the United States.
    Orenstein WA; Markowitz L; Preblud SR; Hinman AR; Tomasi A; Bart KJ
    Dev Biol Stand; 1986; 65():13-21. PubMed ID: 3549395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants.
    Altintaş DU; Evliyaoğlu N; Kilinç B; Sen'an DI; Güneşer S
    Eur J Epidemiol; 1996 Dec; 12(6):647-8. PubMed ID: 8982627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers.
    Szenborn L; Tischer A; Pejcz J; Rudkowski Z; Wójcik M
    Med Sci Monit; 2003 Dec; 9(12):CR541-6. PubMed ID: 14646978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-measles antibodies in the first 2 years of life].
    Echevarría JM; Sainz C; Montón JL; González F; Crespo E; Morales E; Cortés M; Taracena B; Nájera R
    An Esp Pediatr; 1984 Jun; 20(9):847-53. PubMed ID: 6486579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team.
    Markowitz LE; Albrecht P; Rhodes P; Demonteverde R; Swint E; Maes EF; Powell C; Patriarca PA
    Pediatrics; 1996 Jan; 97(1):53-8. PubMed ID: 8545224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The transmission of maternal measles antibodies to newborn infants in the Ivory Coast].
    Rey JL; Lhuillier M; Dem M; Soro B; Saki Z; Davis CE
    Med Trop (Mars); 1991; 51(2):215-8. PubMed ID: 1654494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Measles and mumps antibody concentrations in newborns and their mothers--follow up first year of life].
    Hohendahl J; Peters N; Hüttermann U; Rieger C
    Klin Padiatr; 2006; 218(4):213-20. PubMed ID: 16819702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study.
    Leuridan E; Hens N; Hutse V; Ieven M; Aerts M; Van Damme P
    BMJ; 2010 May; 340():c1626. PubMed ID: 20483946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.